KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015

BACKGROUND: Mutations in KRAS and NRAS often result in constitutive activation of RAS in the epidermal growth factor receptor (EGFR) signaling pathway. Mutations in KRAS exon 2 (codon 12–13) predict resistance to anti-EGFR targeted therapy in patients with metastatic colorectal carcinoma (mCRC). How...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Heliyon
Asıl Yazarlar: Jouini, Raja, Ferchichi, Marwa, BenBrahim, Ehsen, Ayari, Imen, Khanchel, Fatma, Koubaa, Wafa, Saidi, Olfa, Allani, Riadh, Chadli-Debbiche, Aschraf
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430077/
https://ncbi.nlm.nih.gov/pubmed/30949599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2019.e01330
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller